Abstract
That the zinc metalloendopeptidase insulysin (insulin-degrading enzyme IDE) is a major β-amyloid (Aβ) peptide-degrading enzyme in vivo is shown by the higher Aβ peptide levels in the brain of an insulysin-deficient mouse. Insulysin was shown to initially cleave Aβ1–40 and Aβ1–42 at His13-Gln14, His14-Gln15, and Phe19-Phe20. The insulysin-dependent cleavage of Aβ prevents both the neurotoxic effects of the peptide as well as the ability of Aβ to deposit onto synthetic amyloid plaques. The kinetics of the reaction of insulysin with the synthetic peptide substrate Abz-G-G-F-L-R-K-H-G-Q-EDDnp displays allosteric properties indicative of a regulated enzyme. Small peptide substrates increase the activity of insulysin toward the hydrolysis of Aβ1–40 without affecting the activity of the enzyme toward insulin. These studies indicate that insulysin is a target for drug development in which small-molecule peptide analogs can be used to increase the rate of Aβ clearance without affecting insulin levels.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bennett R. G., Duckworth W. C., and Hamel F. G. (2000) Degradation of amylin by insulin-degrading enzyme. J. Biol. Chem. 275, 36621–36625.
Esler W. P., Stimson E. R., Ghilardi J. R., Felix A. M., Lu Y.- A., Vinters H. V., et al. (1997) A beta deposition inhibitor screen using synthetic amyloid. Nat. Biotechnol. 15, 268–263.
Esler W.P., Stimson E. R., Mantyh P. W., and Maggio J. E. (1999) Deposition of soluble amyloid-beta onto amyloid templates: with application for the identification of amyloid fibril extension inhibitors. Methods Enzymol. 309, 350–374.
Farris W., Mansourian S., Chang Y., Lindsley L., Eckman E. A., Frosch M. P., et al. (2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc. Natl. Acad. Sci. U. S. A. 100, 4162–4167.
Garcia V., Gehm B. D., and Rosner M. R. (1989) An evolutionarily conserved enzyme degrades transforming growth factor-alpha as well as insulin. J. Cell Biol. 109, 1301–1307.
Gehm B. D. and Rosner M. R. (1991) Regulation of insulin, epidermal growth factor, and transforming growth factor-alpha levels by growth factor-degrading enzymes. Endocrinology 128, 1603–1610
Hersh L. B. (2003) Peptidases, proteases and amyloid beta-peptide catabolism. Curr. Pharm. Des. 9, 449–454.
Kirschner R. J. and Goldberg A. L. (1983) A high molecular weight metalloendoprotease from the cytosol of mammalian cells. J. Biol. Chem. 258, 967–976.
Kurochkin V. and Goto S. (1994) Alzheimer’s beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett. 345, 33–37
McDermott J. R. and Gibson A. M. (1997) Degradation of Alzheimer’s beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme. Neurochem. Res. 22, 49–56
Miller B. C., Eckman E. A., Sambamurti K., Dobbs N., Chow K. M., Eckman C. B., et al. (2003) Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc. Natl. Acad. Sci. U. S. A. 100, 6221–6226.
Mukherjee A. and Hersh L. B. (2002) Regulation of amyloid beta-peptide levels by enzymatic degradation. J. Alzheimer’s Dis. 4, 341–348.
Mukherjee A., Song E., Kihiko-Ehmann M., Goodman J. P. Jr., Pyrek J. S., Estus S., and Hersh L. B. (2000) Insulysin hydrolyzes amyloid beta peptides to products that are neither neurotoxic nor deposit on amyloid plaques. J. Neurosci. 20, 8745–8749.
Muller D., Baumeister H., Buck F., and Richter D. (1991) Atrial natriuretic peptide (ANP) is a high-affinity substrate for rat insulin-degrading enzyme. Eur. J. Biochem. 202, 285–292.
Muller D., Schulze C., Baumeister H., Buck F., and Richter D. (1992) Rat insulin-degrading enzyme: cleavage pattern of the natriuretic peptide hormones ANP, BNP, and CNP revealed by HPLC and mass spectrometry. Biochemistry 31, 11138–11143
Safavi A., Miller B. C., Cottam L., and Hersh L. B. (1996) Identification of gamma-endorphin-generating enzyme as insulin-degrading enzyme. Biochemistry 35, 14318–14325.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Song, E.S., Hersh, L.B. Insulysin. J Mol Neurosci 25, 201–206 (2005). https://doi.org/10.1385/JMN:25:3:201
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:25:3:201